Baxter Recalls Sodium Chloride Bags Over Fiberglass
Baxter Healthcare Corporation recalled 500 mL VIAFLEX sodium chloride containers after the FDA identified fiberglass particulates.
Baxter International (BAX) recalled 0.9% Sodium Chloride Injection USP 500 mL VIAFLEX plastic containers after the FDA identified fiberglass particulates in the product.
The recalling firm, Baxter Healthcare Corporation of Deerfield, Illinois, issued a voluntary, firm-initiated Class I recall on Sept. 9, 2026, under recall number D-0849-2026. The product is NDC 0338-0049-03, made in the USA, with 24 units per case. The FDA stated the reason as the presence of particulate matter identified as fiberglass. The agency listed the status as ongoing and distribution as nationwide in the USA.
On Aug. 18, 2026, Baxter International Inc. appointed John Rogers as executive vice president and chief financial officer, effective Oct. 1, 2026. Rogers, 58, joined from Smith+Nephew plc, where he had served as CFO since 2024. His target direct compensation includes a $925,000 base salary, a 100% target bonus, and a $4,000,000 target annual equity grant beginning with the 2027 cycle.
Baxter Healthcare Corporation had already issued a Class I recall on Sept. 16, 2026, for Dextrose Injection, USP, 70%, 2000 mL bags (NDC 00338-0719-06), citing stainless steel particles in the solution. That recall was also voluntary, firm-initiated, ongoing, and distributed U.S. nationwide.
In September 2024, the same firm recalled three EXACTAMIX inlet products used in pharmaceutical compounding devices after increased customer reports of particulate matter in disposable inlets and sterile fluid-path tubing. Those recalls were voluntary, firm-initiated, ongoing, and distributed worldwide.
The sodium chloride recall remains open as of the FDA record, with the company continuing its voluntary pull of the fiberglass-affected VIAFLEX containers.